Showing 1 - 3 results of 3 for search 'Véronique Olislagers', query time: 0.02s
Refine Results
-
1
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial. by Pieter Pannus, Stéphanie Depickère, Delphine Kemlin, Sarah Houben, Kristof Y Neven, Leo Heyndrickx, Johan Michiels, Elisabeth Willems, Stéphane De Craeye, Antoine Francotte, Félicie Chaumont, Véronique Olislagers, Alexandra Waegemans, Mathieu Verbrugghe, Marie-Noëlle Schmickler, Steven Van Gucht, Katelijne Dierick, Arnaud Marchant, Isabelle Desombere, Kevin K Ariën, Maria E Goossens
Published 2022-01-01
Article -
2
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial by Pieter Pannus, Stéphanie Depickère, Delphine Kemlin, Sarah Houben, Kristof Y. Neven, Leo Heyndrickx, Johan Michiels, Elisabeth Willems, Stéphane De Craeye, Antoine Francotte, Félicie Chaumont, Véronique Olislagers, Alexandra Waegemans, Mathieu Verbrugghe, Marie-Noëlle Schmickler, Steven Van Gucht, Katelijne Dierick, Arnaud Marchant, Isabelle Desombere, Kevin K. Ariën, Maria E. Goossens
Published 2022-01-01
Article -
3
Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality by Philomène Lavis, Philomène Lavis, Sofia Morra, Carmen Orte Cano, Nurhan Albayrak, Véronique Corbière, Véronique Olislagers, Nicolas Dauby, Nicolas Dauby, Véronique Del Marmol, Arnaud Marchant, Christine Decaestecker, Christine Decaestecker, Françoise Mascart, Nathalie De Vos, Philippe Van de Borne, Philippe Van de Borne, Isabelle Salmon, Isabelle Salmon, Isabelle Salmon, Myriam Remmelink, Marc Parmentier, Alessandra Kupper Cardozo, Benjamin Bondue, Benjamin Bondue
Published 2022-08-01
Article